PRODUCT HIGHLIGHTS:
- Oral Probiotic for Natural Vaginal Health
- Clinically-Documented Benefits
- 20+ Years of Clinical Research
- Patented Lactobacilli: GR-1 and RC-14
- Prevention Magazine: Top 10 Breakthrough
fem-dophilus contains two patented and clinically documented probiotic strains, Lactobacillus rhamnosus, GR-1 and Lactobacillus reuteri, RC-14, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 20 years of research supports the oral use of GR-1 and RC-14 to colonize and protect the vaginal tract.
Clinical trials have shown that GR-1 and RC-14:
- Help to maintain or restore healthy vaginal flora that are important in maintaining vaginal health
- Support the health of the urinary tract
fem-dophilus is manufactured under pharmaceutical GMP conditions with guaranteed potency and consistency. The probiotic strains in fem-dophilus are in a proprietary polysaccharide matrix, which protects the bacteria from stomach acid and enhances probiotic bacteria survival to the lower intestine.
Keep out of the reach of children.
|
Suggested Usage:
For maintenance, take 1 capsule orally per day and increase to 2 capsules per day as needed, or take as directed by your qualified health care consultant.
Keep Refrigerated
Other Ingredients:
Dextrose anhydrate, potato starch, cellulose and magnesium stearate (vegetable source). Capsule consists of gelatin and titanium dioxide.
Contains: Dairy (casein, in trace amounts).
No wheat, no gluten, no soybeans, no egg, no fish/shellfish, no peanuts/tree nuts.

|